All seven director nominees elected: René Sindlev, Mark Dybul, Carol Brosgart, Gregg Alton, James Sapirstein, Henrik Gronfeldt-Sorensen, Jayne McNicol.
2023 Equity Incentive Plan approved with 18,785,519 votes for, 34,914 against, 1,528,369 broker non-votes.
Ratification of Sadler, Gibb & Associates as independent auditor passed: 20,327,508 for, 16,107 against, 13,456 abstain.
Extracted from this filing and checked against the source text.
Shareholder VotesSEC 8-K Item 5.07confidence 0.95
Lunai Bioworks Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2023-07-21 meeting.
Proposal
auditor ratification
Outcome
passed
Meeting
2023-07-21
Exact text from the filing
Proposal No. 3 : Ratification of Independent Registered Public Accounting Firm . The stockholders ratified Sadler, Gibb & Associates, LLC as the Company's independent registered public accounting firm as follows: Votes For 20,327,508 Votes Against 16,107 Abstentions 13,456
Lunai Bioworks Inc. shareholders approved Approval of 2023 Equity Incentive Plan at the 2023-07-21 meeting.
Proposal
equity plan
Outcome
passed
Meeting
2023-07-21
Exact text from the filing
Proposal No. 2 : Approval of 2023 Equity Incentive Plan . The stockholders approved the 2023 Equity Incentive Plan as follows: Votes For 18,785,519 Votes Against 34,914 Abstentions 8,269 Broker Non-Votes 1,528,369
Lunai Bioworks Inc. shareholders approved Election of Directors at the 2023-07-21 meeting.
Proposal
director election
Outcome
passed
Meeting
2023-07-21
Exact text from the filing
Proposal No. 1 : The election of Renè Sindlev, Dr. Mark R. Dybul, Dr. Carol L. Brosgart, Gregg Alton, James Sapirstein, Henrik Gronfeldt-Sorensen and Jayne McNicol for terms until the next annual meeting of stockholders or until each such director's successor shall have been duly elected and qualified . The stockholders elected each of the seven directors by the following votes: Director Votes For Votes Withheld Broker Non-Votes Renè Sindlev 18,661,936 166,766 1,528,369 Dr. Mark R. Dybul 18,662,825 165,877 1,528,369 Dr. Carol L. Brosgart 18,652,095 176,607 1,528,369 Gregg Alton 17,343,287 1,485,415 1,528,369 James Sapirstein 17,122,111 1,706,591 1,528,369 Henrik Gronfeldt-Sorensen 18,659,827 168,875 1,528,369 Jayne McNicol 17,247,573 1,581,129 1,528,369
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.